Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Soft Tissue Sarcoma: early-phase trial registry
22 of 56 indexed Soft Tissue Sarcoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #252 of 28,707 conditions by registered trial count.
56 US clinical trials · 22 currently recruiting · #252 of 28,707 conditions by registered trial count
Soft Tissue Sarcoma: 56 US clinical trials tracked, 22 recruiting.
Soft Tissue Sarcoma is the subject of 56 registered US clinical trials on ClinicalTrials.gov, 22 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 43 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 4 of these trials.
Enrollment posture brief
Registry condition soft-tissue-sarcoma
OPEN 22 | RECR 39% | LATE 2 | EARLY 43 | RANK #252 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Eye Diseases (39% recruiting · 28 trials)
Soft Tissue Sarcoma lists 22 open slots (39% of 56 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Soft Tissue Sarcoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Soft Tissue Sarcoma recruits in line with its size-band peers.
22 of 56 indexed trials (39.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Soft Tissue Sarcoma trials is spread across many organizations.
Memorial Sloan Kettering Cancer Center accounts for 4 of 56 trials (7.1%). 42 distinct sponsors appear on at least one study for this condition label.
-
Most Soft Tissue Sarcoma trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 56 trials that report a genuine target (sentinel values excluded). 47 of those (83.9%) plan for fewer than 100 participants.
-
Soft Tissue Sarcoma research is mostly interventional.
52 interventional and 4 observational studies make up this index (92.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
56 total, page 2 of 2
TVEC and Preop Radiation for Sarcoma (4 ml Dose)
University of Iowa
NCT02453191
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
Columbia University
NCT00629343
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Eli Lilly and Company
NCT03283696
Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
Gem Pharmaceuticals
NCT02267083
Bevacizumab and Radiation Therapy for Sarcomas
Massachusetts General Hospital
NCT00356031
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Timothy Cripe
NCT00931931
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 20 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Soft Tissue Sarcoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Soft Tissue Sarcoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Soft Tissue Sarcoma page
56 registered trials, 22 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 22 Soft Tissue Sarcoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Memorial Sloan Kettering Cancer Center sponsors the most Soft Tissue Sarcoma trials on record, review their full trial history before evaluating a specific study. See Memorial Sloan Kettering Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Soft Tissue Sarcoma condition card totals 56 registered trials; most-linked intervention Gemcitabine; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.